Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Int J Neuropsychopharmacol. 2009 Mar 17;13(1):10.1017/S1461145709000169. doi: 10.1017/S1461145709000169

Fig. 2.

Fig. 2

Phase 1 response (□) and remission (■) rates. Response and remission rates 24-h and 72-h following a single infusion of intravenous ketamine (0.5 mg/kg over 40 min) in treatment-resistant major depression (n = 26), determined by MADRS and QIDS-SR16.